You have 9 free searches left this month | for more free features.

Azacitidine

Showing 551 - 575 of 685

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in

Completed
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • +11 more
  • Madison, Wisconsin
    University of Wisconsin Hospital and Clinics
Nov 13, 2019

Myelodysplastic Syndrome Trial in Houston (OPN-305)

Completed
  • Myelodysplastic Syndrome
  • Houston, Texas
    Research Site
Jan 24, 2019

Lymphoma, Hodgkin Disease, Lymphoma, Non-Hodgkin Trial in Lexington (Azacitidine with rituximab, vincristine, and

Completed
  • Lymphoma
  • +2 more
  • Azacitidine with rituximab, vincristine, and cyclophosphamide
  • Lexington, Kentucky
    University of Kentucky
Oct 13, 2016

Hematopoietic System--Cancer Trial (Decitabine)

Unknown status
  • Hematopoietic System--Cancer
  • (no location specified)
Sep 30, 2018

Chronic Myelomonocytic Leukemia, de Novo MDS, MDS Trial in Cleveland (other, drug, genetic)

Completed
  • Chronic Myelomonocytic Leukemia
  • +7 more
  • flow cytometry
  • +7 more
  • Cleveland, Ohio
  • +1 more
Feb 21, 2019

MDS Trial in Italy (5-Azacytidine, Valproic Acid, ATRA)

Completed
  • Myelodysplastic Syndromes
  • Arezzo, Italy
  • +6 more
Aug 4, 2018

Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL) Trial in United States (CB-839, CB-Aza)

Completed
  • Acute Myeloid Leukemia (AML)
  • Acute Lymphocytic Leukemia (ALL)
  • Denver, Colorado
  • +4 more
Feb 7, 2017

Acute Myeloid Leukemia Trial (OTX015, Vidaza (azacitidine))

Withdrawn
  • Acute Myeloid Leukemia
  • (no location specified)
Aug 31, 2016

Myelodysplastic Syndrome Trial in United States (OPN-305)

Completed
  • Myelodysplastic Syndrome
  • Tampa, Florida
  • +3 more
Jan 24, 2019

Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma Trial in

Terminated
  • Stage IA Non-Small Cell Lung Carcinoma
  • +4 more
  • Azacitidine
  • +4 more
  • Lexington, Kentucky
  • +2 more
Nov 17, 2016

Myelodysplastic Syndrome Trial in New York (Tosedostat)

Completed
  • Myelodysplastic Syndrome
  • New York, New York
    Weill Cornell Medical College
Jun 7, 2018

Acute Myeloid Leukemia Trial in Worldwide (Azacitidine, Conventional Care Regimen)

Completed
  • Acute Myeloid Leukemia
  • Azacitidine
  • Conventional Care Regimen
  • Boston, Massachusetts
  • +111 more
Aug 25, 2017

Follicular Lymphoma, Marginal Zone Lymphoma Trial in Durham (azacitidine, lenalidomide)

Terminated
  • Follicular Lymphoma
  • Marginal Zone Lymphoma
  • Durham, North Carolina
    Duke University Medical Center
Aug 1, 2016

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Pittsburgh (5-azacytidine (5-aza) maintenance therapy

Withdrawn
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • 5-azacytidine (5-aza) maintenance therapy after transplant
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Mar 29, 2018

Myelodysplastic Syndrome, MDS Trial in United States (pracinostat, Azacitidine, Decitabine)

Completed
  • Myelodysplastic Syndrome
  • MDS
  • Mobile, Alabama
  • +20 more
Feb 22, 2017

Prostate Cancer, Pain Trial in Miami (Azacitidine, Docetaxel, Prednisone)

Terminated
  • Prostate Cancer
  • Pain
  • Azacitidine
  • +5 more
  • Miami, Florida
    University of Miami Sylvester Comprehensive Cancer Center
May 3, 2016

Acute Myeloid Leukemia (AML) With Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults, AML (Adult) With 11q23

Terminated
  • Acute Myeloid Leukemia (AML) With Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults
  • +7 more
  • Stanford, California
    Stanford University School of Medicine
Sep 25, 2018

Chronic Myelomonocytic Leukemia Trial in Buffalo, Portland, Salt Lake City (5-Azacitidine)

Completed
  • Chronic Myelomonocytic Leukemia
  • Buffalo, New York
  • +2 more
May 10, 2016

Lymphoma Trial (Busulfan, Caphosol, Glutamine)

Withdrawn
  • Lymphoma
  • (no location specified)
May 3, 2016

Leukemia Trial in Houston (Azacitidine, Sorafenib)

Completed
  • Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
Mar 31, 2016

Myelodysplastic Syndrome Trial in United States (Birinapant, 5-Azacitidine)

Completed
  • Myelodysplastic Syndrome
  • Glendale, Arizona
  • +6 more
Apr 19, 2016

Chronic Myelomonocytic Leukemia-2, Myelodysplastic Syndrome, Myeloproliferative Tumor Trial in United States (Cytarabine,

Completed
  • Chronic Myelomonocytic Leukemia-2
  • +3 more
  • Bozeman, Montana
  • +8 more
Apr 11, 2018

SMD Trial in France (ACADESINE 140mg/kg/d, ACADESINE 210mg/kg/d, ACADESINE 315mg/kg/d)

Terminated
  • SMD
  • ACADESINE 140mg/kg/d
  • +2 more
  • Bayonne, France
  • +16 more
Nov 7, 2016